浏览全部资源
扫码关注微信
1.兰州大学第二医院(第二临床医学院),兰州;730030
2.兰州大学第二医院(第二临床医学院)肾内科,兰州 730030
3.兰州大学第二医院(第二临床医学院)肾病重点实验室,兰州 730030
4.甘肃省肾病临床医学研究中心,兰州 730030
Published:30 November 2024,
Received:02 July 2024,
Revised:25 October 2024,
移动端阅览
李子依,王冰如,高万梅等.不同方式治疗中重度过敏性紫癜肾炎有效性与安全性的网状Meta分析 Δ[J].中国药房,2024,35(22):2808-2814.
LI Ziyi,WANG Bingru,GAO Wanmei,et al.Efficacy and safety of different treatments for moderate to severe Henoch-Schönlein purpura nephritis: a network meta-analysis[J].ZHONGGUO YAOFANG,2024,35(22):2808-2814.
李子依,王冰如,高万梅等.不同方式治疗中重度过敏性紫癜肾炎有效性与安全性的网状Meta分析 Δ[J].中国药房,2024,35(22):2808-2814. DOI: 10.6039/j.issn.1001-0408.2024.22.18.
LI Ziyi,WANG Bingru,GAO Wanmei,et al.Efficacy and safety of different treatments for moderate to severe Henoch-Schönlein purpura nephritis: a network meta-analysis[J].ZHONGGUO YAOFANG,2024,35(22):2808-2814. DOI: 10.6039/j.issn.1001-0408.2024.22.18.
目的
2
评价不同方式治疗中重度过敏性紫癜肾炎(HSPN)的有效性和安全性。
方法
2
检索中国知网、维普网、万方数据、中国生物医学文献服务系统、PubMed、OVID、Web of Science、Embase、the Cochrane Library,收集单用糖皮质激素(GC),环磷酰胺、霉酚酸酯、雷公藤多苷、来氟米特、咪唑立宾、他克莫司、环孢素A、血液灌流、扁桃体切除联合GC,以及双重血浆置换联合GC与环磷酰胺、双重血浆置换联合GC与霉酚酸酯共12种干预措施治疗中重度HSPN的随机对照试验(RCT)和队列研究,检索时限为建库至2024年3月。筛选文献、提取资料、评价文献质量后,采用Stata 16.0软件进行网状Meta分析。
结果
2
共纳入28篇文献,RCT和队列研究均为14篇,共计1 746例患者。网状Meta分析结果显示,总缓解率方面,他克莫司联合GC最优的概率最大,其次为雷公藤多苷联合GC、双重血浆置换联合GC与霉酚酸酯;完全缓解率方面,来氟米特联合GC最优的概率最大,其次为咪唑立宾联合GC、双重血浆置换联合GC与环磷酰胺;降低24 h尿蛋白定量方面,咪唑立宾联合GC最优的概率最大,其次为双重血浆置换联合GC与霉酚酸酯、来氟米特联合GC;安全性方面,他克莫司联合GC最优的概率最大,其次为环孢素A联合GC、来氟米特联合GC。
结论
2
相较于其他治疗方式,他克莫司联合GC治疗中重度HSPN的疗效和安全性均较好。
OBJECTIVE
2
To assess the efficacy and safety of different treatment modalities for moderate to severe Henoch-Schönlein purpura nephritis (HSPN).
METHODS
2
Literature searches were conducted in the CNKI, VIP, Wanfang Data, SinoMed, PubMed, OVID, Web of Science, Embase, and the Cochrane Library to collect randomized controlled trials (RCTs) and cohort studies on the treatment of moderate to severe HSPN with 12 intervention measures: monotherapy with glucocorticoid (GC), as well as cyclophosphamide, mycophenolate mofetil (MMF),
Tripterygium wilfordii
multiglucoside (TWM), leflunomide, mizoribine, tacrolimus, cyclosporin A, hemoperfusion, tonsillectomy combined with GC, and double filtration plasmapheresis (DFPP) combined with GC and cy
clophosphamide or mycophenolate mofetil. The search period was from the inception of the databases to March 2024. After literature screening, data extraction, and quality assessment, a network meta-analysis was performed using Stata 16.0 software.
RESULTS
2
A total of 28 articles were included, with 14 RCTs and 14 cohort studies, involving 1 746 patients. The network meta-analysis results showed the combination of tacrolimus and GC had the highest probability of being the best in overall remission rate, followed by the combination of TWM and GC, and DFPP combined with GC and MMF. The combination of leflunomide and GC had the highest probability of being the best in complete remission rate, followed by the combination of mizoribine and GC, and DFPP combined with GC and cyclophosphamide. The combination of mizoribine and GC had the highest probability of being the best in terms of reducing 24-hour urinary protein quantification, followed by DFPP combined with GC and MMF, and the combination of leflunomide and GC. Moreover, the combination of tacrolimus and GC had the highest probability of being the best in safety, followed by the combination of cyclosporin A and GC, and the combination of leflunomide and GC.
CONCLUSIONS
2
Compared to other treatment methods, the combination therapy of tacrolimus and GC shows better efficacy and safety in the treatment of moderate to severe HSPN.
过敏性紫癜肾炎糖皮质激素免疫抑制剂网状Meta分析有效性安全性
glucocorticoidimmunosuppressantnetwork meta-analysisefficacysafety
ZHU Y J,DONG Y,LI Y F,et al. Adding methylprednisolone and cyclophosphamide pulse therapy provides no benefit in pediatric IgAV nephritis grade Ⅲ[J]. Clin Pediatr,2023,62(6):615-621.
UMEDA C,FUJINAGA S,ENDO A,et al. Preventive effect of tonsillectomy on recurrence of Henoch-Schönlein purpura nephritis after intravenous methylprednisolone pulse therapy[J]. Tohoku J Exp Med,2020,250(1):61-69.
CHEN L N,WANG Z,ZHAI S H,et al. Effects of hemoperfusion in the treatment of childhood Henoch-Schönlein purpura nephritis[J]. Int J Artif Organs,2013,36(7):489-497.
YU Y,CHEN J J,YIN H L,et al. Efficacy of steroid and immunosuppressant combined therapy in Chinese patients with Henoch-Schönlein purpura nephritis:a retrospective study[J]. Int Immunopharmacol,2020,81:106229.
HIGGINS J P T,ALTMAN D G,GØTZSCHE P C,et al. The Cochrane collaboration’s tool for assessing risk of bias in randomised trials[J]. BMJ,2011,343:d5928.
STANG A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J]. Eur J Epidemiol,2010,25(9):603-605.
WU L,MAO J H,JIN X,et al. Efficacy of triptolide for children with moderately severe Henoch-Schönlein purpura nephritis presenting with nephrotic range proteinuria:a prospective and controlled study in China[J]. Biomed Res Int,2013,2013:292865.
LU Z H,SONG J F,MAO J H,et al. Evaluation of mycophenolate mofetil and low-dose steroid combined therapy in moderately severe Henoch-Schönlein purpura nephritis[J]. Med Sci Monit,2017,23:2333-2339.
ZHANG Y J,GAO Y,ZHANG Z X,et al. Leflunomide in addition to steroids improves proteinuria and renal function in adult Henoch-Schöenlein nephritis with nephrotic proteinuria[J]. Nephrology,2014,19(2):94-100.
HAN F,CHEN L L,REN P P,et al. Mycophenolate mofetil plus prednisone for inducing remission of Henoch-Schönlein purpura nephritis:a retrospective study[J]. J Zhejiang Univ Sci B,2015,16(9):772-779.
REN P P,HAN F,CHEN L L,et al. The combination of mycophenolate mofetil with corticosteroids induces remission of Henoch-Schönlein purpura nephritis[J]. Am J Nephrol,2012,36(3):271-277.
KAWASAKI Y,SUZUKI J,SUZUKI H. Efficacy of me-thylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schönlein nephritis:a clinical and histopathological study[J]. Nephrol Dial Transplant,2004,19(4):858-864.
王菁,李莉. 环磷酰胺联合卡托普利和甲泼尼龙治疗紫癜性肾炎的临床研究[J]. 药物评价研究,2021,44(7):1458-1462.
WANG J,LI L. Clinical study of cyclophosphamide combined with captopril and methylprednisolone in treatment of purpura nephritis[J]. Drug Eval Res,2021,44(7):1458-1462.
刘娜,马忠正,严慧芳,等. 双重血浆置换联合激素与免疫抑制剂治疗儿童重症紫癜性肾炎的临床效果[J]. 中国当代儿科杂志,2019,21(10):955-959.
LIU N,MA Z Z,YAN H F,et al. Clinical effect of double filtration plasmapheresis combined with glucocorticoid and immunosuppressant in treatment of children with severe Henoch-Schönlein purpura nephritis[J]. Chin J Contemp Pediatr,2019,21(10):955-959.
李丽娜,赵洪雯,申兵冰,等. 他克莫司与吗替麦考酚酯治疗紫癜性肾炎的回顾性对照研究[J]. 第三军医大学学报,2016,38(10):1173-1177.
LI L N,ZHAO H W,SHEN B B,et al. Tacrolimus versus mycophenolate mofetil for therapy of Henoch-Schönlein purpura nephritis:a retrospective comparison trial[J]. J Third Mil Med Univ,2016,38(10):1173-1177.
孙立宁,曾聪灵,郭修枢,等. 双重血浆置换联合甲泼尼龙、霉酚酸酯双冲击疗法对重症紫癜性肾炎患儿免疫功能和肾功能的影响[J]. 疑难病杂志,2020,19(7):700-704.
SUN L N,ZENG C L,GUO X S,et al. The effect of double plasma exchange combined with methylprednisolone and mycophenolate mofetil on immune function and renal function in children with severe purpura nephritis[J]. Chin J Difficult Complicat Cases,2020,19(7):700-704.
李英,桂明,李杨. 免疫抑制剂治疗肾病综合征型紫癜肾炎的临床疗效比较[J]. 临床医学工程,2011,18(3):347-349.
LI Y,GUI M,LI Y. Comparison of three kinds of immunosuppressor treatment in nephropathy syndrome caused by Henoch-Schönlein purpura nephritis[J]. Clin Med Eng,2011,18(3):347-349.
李良志,刘雷,何先红,等. 咪唑立宾治疗重症过敏性紫癜性肾炎21例疗效观察[J]. 重庆医学,2010,39(14):1904-1906.
LI L Z,LIU L,HE X H,et al. Clinical observation on 21 cases of severe Henoch-Schönlein purpura nephritis treated with mizoribine[J]. Chongqing Med,2010,39(14):1904-1906.
林炯程,胡伟新,唐政,等. 霉酚酸酯与环磷酰胺治疗重症过敏紫癜性肾炎的疗效比较[J]. 肾脏病与透析肾移植杂志,2005,14(6):508-513.
LIN J C,HU W X,TANG Z,et al. Mycophenolate mofetil therapy versus intermittent cyclophosphamide pulse treatment in patients with severe Henoch-Schönlein purpura nephritis[J]. Chin J Nephrol Dial Transplant,2005,14(6):508-513.
张志芳. 霉酚酸酯联合激素治疗肾病综合征型紫癜性肾炎27例临床观察[J]. 山西医药杂志,2006,35(1):66-67.
ZHANG Z F. Clinical observation on mycophenolate mofetil combined with hormone in the treatment of 27 cases of nephrotic syndrome purpura nephritis[J]. Shanxi Med J,2006,35(1):66-67.
刘大军,杜威,刘葵. 来氟米特治疗过敏性紫癜肾炎的临床观察[J]. 中国现代医学杂志,2012,22(15):57-61.
LIU D J,DU W,LIU K. Clinical observation of the effect of leflunomide on purpuric nephritis nephrotic syndrome[J]. China J Mod Med,2012,22(15):57-61.
孙剑,张浩,刘纪实,等. 来氟米特与霉酚酸酯治疗表现为肾病综合征的过敏紫癜性肾炎的疗效比较[J]. 中国中西医结合肾病杂志,2008,9(8):691-693.
SUN J,ZHANG H,LIU J S,et al. Comparison between leflunomide and mycophenolate mofetil treatment in nephropathy syndrome caused by Henoch-Schönlein purpura nephritis[J]. Chin J Integr Tradit West Nephrol,2008,9(8):691-693.
白玲,马兰红,麦迪娜,等. 环孢素A联合甲泼尼龙冲击治疗重症紫癜性肾炎患儿的疗效及对蛋白尿、VCAM-1和VEGF的影响[J]. 西部医学,2021,33(5):693-696,700.
BAI L,MA L H,MAI D N,et al. The efficacy of cyclosporine A combined with methylprednisolone in the treatment of children with severe purpuric nephritis and its effect on proteinuria,VCAM-1 and VEGF[J]. Med J West China,2021,33(5):693-696,700.
宣萍. 205例成人过敏性紫癜性肾炎的临床特征与治疗分析[D]. 杭州:浙江大学,2014.
XUAN P. Clinical characteristics and treatment of 205 cases of adult Henoch-Schönlein purpura nephritis[D].Hangzhou:Zhejiang University,2014.
耿海云,陈朝英,李华荣,等. 霉酚酸酯和环磷酰胺治疗儿童大量蛋白尿型过敏性紫癜性肾炎的前瞻性随机对照研究[J]. 中国当代儿科杂志,2021,23(4):338-342.
GENG H Y,CHEN C Y,LI H R,et al. Efficacy and safety of mycophenolate mofetil versus cyclophosphamide in the treatment of Henoch-Schönlein purpura nephritis with nephrotic-range proteinuria in children:a prospective randomized controlled trial[J]. Chin J Contemp Pediatr,2021,23(4):338-342.
陈金花,郭雨,覃琳. 他克莫司与环磷酰胺分别联合激素治疗小儿Ⅲ~Ⅳ级紫癜性肾炎的对比研究[J]. 中国中西医结合肾病杂志,2022,23(8):728-730.
CHEN J H,GUO Y,QIN L. Comparative study of tacrolimus and cyclophosphamide combined with hormone in the treatment of grade Ⅲ-Ⅳ Henoch-Schönlein purpura nephritis in children[J]. Chin J Integr Tradit West Nephrol,2022,23(8):728-730.
吴登艳. 他克莫司治疗儿童过敏性紫癜性肾炎的有效性及安全性研究[D]. 兰州:兰州大学,2021.
WU D Y. Efficacy and safety of tacrolimus in the treatment of Henoch-Schönlein purpura nephritis in children[D]. Lanzhou:Lanzhou University,2021.
高罡. 霉酚酸酯+甲泼尼龙双冲击疗法联合DFPPD对HSPN患儿的疗效[J]. 山西卫生健康职业学院学报,2022,32(6):75-77.
GAO G. The therapeutic effect of mycophenolate mofetil and methylprednisolone double shock therapy combined with DFPPD on children with HSPN[J]. J Shanxi Health Vocat Coll,2022,32(6):75-77.
王一冰,李强,李晶,等. 来氟米特与环磷酰胺治疗HSPN效果比较[J].齐鲁医学杂志,2009,24(5):424-426.
WANG Y B,LI Q,LI J,et al. Leflunomide and cyclopho-sphamide:a comparison of their efficacy for Henoch-Schönlein purpura nephritis[J]. Med J Qilu,2009,24(5):424-426.
杨磊,郭明好,刘云. 来氟米特治疗肾病综合征表现的紫癜肾临床观察[J]. 现代泌尿外科杂志,2009,14(5):353-355.
YANG L,GUO M H,LIU Y. Leflunomide in treating purpura nephritis with nephritic syndrome[J]. J Mod Urol,2009,14(5):353-355.
邢二庆,刘玉霞,尚家星. 甲泼尼龙+环磷酰胺冲击治疗联合双重血浆置换在重症紫癜性肾炎患儿中的应用观察[J]. 中国医学工程,2021,29(6):113-116.
XING E Q,LIU Y X,SHANG J X. Observation on the application of methylprednisolone+cyclophosphamide pulse therapy combined with double plasma exchange in children with severe purple epilepsy nephritis[J]. China Med Eng,2021,29(6):113-116.
中华医学会儿科学分会肾脏学组.紫癜性肾炎诊治循证指南:2016[J].中华儿科杂志,2017,55(9):647-651.
Subspecialty Group of Renal Diseases,the Society of Pediatrics,Chinese Medical Association. Evidence-based guideline for diagnosis and treatment of Henoch-Schönlein purpura nephritis:2016[J]. Zhonghua Er Ke Za Zhi,2017,55(9):647-651.
WU D Y,MA R,WANG X M,et al. Efficacy and safety of tacrolimus in the treatment of pediatric Henoch-Schönlein purpura nephritis[J]. Paediatr Drugs,2022,24(4):389-401.
HOU L,ZHANG Z,DU Y. Leflunomide therapy for IgA vasculitis with nephritis in children[J]. BMC Pediatr,2021,21(1):391.
KAWASAKI Y,SUYAMA K,HASHIMOTO K,et al. Methylprednisolone pulse plus mizoribine in children with Henoch-Schönlein purpura nephritis[J]. Clin Rheumatol,2011,30(4):529-535.
NGUYEN B,ACHARYA C,TANGPANITHANDEE S,et al. Efficacy and safety of plasma exchange as an adjunctive therapy for rapidly progressive IgA nephropathy and Henoch-Schönlein purpura nephritis:a systematic review[J]. Int J Mol Sci,2023,24(4):3977.
KAWASAKI Y,SUYAMA K,MATSUMOTO A,et al. Efficacy of tonsillectomy plus methylprednisolone pulse therapy for a child with Henoch-Schönlein purpura nephritis[J]. Tohoku J Exp Med,2007,211(3):291-295.
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution